Tempus AI, Inc. (TEM) › Analysis

Tempus AI (TEM) stock analysis, November 16, 2026: Pullback oversold, bullish bias

Published November 16, 2026 · TEM chart, levels and live analysis

Tempus AI, Inc. (TEM) fell more than 6% on November 15, snapping a brief rally and leaving the price at $66.84, well below the 50‑day SMA of $72.88. The drop represents a pullback inside a weekly uptrend that has now entered oversold territory, keeping the medium‑conviction bullish case for the next two to six weeks intact. The balance of evidence still leans positive, but the move has eroded much of the upside upside potential until a daily close above $70 on volume above the 20‑day average re‑establishes the breakout math.

Why it matters

The immediate catalyst was the release of TEM’s Q3 2026 earnings on November 2, which showed revenue of $411.5 million, up 23% year‑over‑year, and a narrowed net loss of $14.9 million, an 81% improvement. The earnings beat the revenue growth expectations and dramatically reduced the loss profile, yet the stock still slid sharply on the day after the report and continued to fall over the following week. The market appears to have priced in the top‑line growth but remained nervous about the lingering loss and the broader health‑sector rotation.

Sector‑wide dynamics provide additional context. The healthcare sector ETF XLV was up 0.7% over the past five days, while the S&P 500 fell 1.2% in the same period. TEM’s 5‑day performance of –20.85% therefore reflects a relative underperformance of roughly 21.5 percentage points versus its sector, confirming that the move was driven more by stock‑specific concerns than by a sector swing.

Analyst coverage remains broadly supportive: 18 analysts rate the stock as a “buy” with a mean price target of $89.56, a low of $70 and a high of $120. The current price is about 25% below the mean target, indicating that the consensus still sees substantial upside. However, the valuation spread is wide, and the consensus low of $70 sits just above the breakout level of $70, suggesting that many analysts view a move above that round number as a key catalyst.

There is no active debate in the public commentary that directly challenges the bullish thesis. The only notable dissent comes from a pending legal investigation into a proposed merger between Personalis and TEM, raised by Bleichmar Fonti & Auld LLP on October 27. The investigation questions the fairness of the $16.25 per share merger price, but no concrete impact on the stock price has materialized yet, and the news has not moved the price beyond the broader pullback narrative.

In sum, the earnings beat was largely absorbed, the sector backdrop was neutral to slightly positive, and the legal probe has not yet translated into price pressure. The pullback therefore appears to be a technical correction rather than a fundamental reversal.

What the evidence says

On the long‑term horizon, the thesis that TEM is in an uptrend remains intact. The price sits above its 40‑week average, the 52‑week high is still $85.08, and the 52‑week low is $41.55, leaving the stock roughly 21% below its high but 61% above its low. The weekly trend is still upward, and the swing‑zone support at $61.72 holds, meaning the long‑term structure has not been broken.

Looking ahead to the next two‑to‑six weeks, the balance of evidence leans positive, but only with medium conviction. Two of four conviction points are satisfied: the pullback has entered oversold territory (RSI 42.9) and historical patterns after a one‑day drop of more than 5% show a 70.9% chance of a higher close a month later. The other two points—relative underperformance versus the S&P 500 (‑5.9% over 50 days) and versus XLV (‑15.3% over 50 days)—pull the conviction down to medium. The breakout math requires a daily close above $70 on volume above the 20‑day average; until that occurs, the upside remains limited.

The strongest case against a near‑term rebound is the sharp 5‑day decline of –20.85% and the fact that volume is 79.7% below its 20‑day average, indicating weak buying pressure. Moreover, the stock is still trading well below the 50‑day SMA of $72.88, a key resistance level that has not been tested since the recent peak of $84.44 on November 9. These factors keep the conviction from rising to high.

Levels that matter

The price structure currently holds above the swing‑zone support at $61.72, which is derived from the most recent swing low. A break below that level would signal the first crack in the weekly uptrend. The trend would be considered ended if price falls beneath $57.88, the lower swing‑zone boundary that also coincides with the 200‑day SMA at $57.49. Both levels are anchored in the longer‑term price action and serve as the floor for the current bias.

The breakout level is a round $70 close on volume exceeding the 20‑day average. If the price closes above $70, the math projects a first target at $72.88 (the 50‑day SMA) with a reward‑to‑risk ratio of 0.3, and a secondary target at $85.08 (the 52‑week high) with a reward‑to‑risk of 1.5. Because the reward‑to‑risk does not reach the 3‑to‑1 threshold, a higher breakout price—approximately $78—would be needed to achieve a 3‑to‑1 profile. Until such a move occurs, the upside remains modest relative to the downside risk.

What would change the picture

A weekly close below the swing‑zone level of $57.88 would invalidate the current bullish bias and signal that the weekly trend has flipped. The non‑price catalyst that could also shift the narrative is a decisive outcome from the legal investigation into the Personalis‑TEM merger; a ruling that the deal is unfair or blocked would add a fundamental headwind beyond the technical picture.

What to watch

Get a message when the TEM picture changes — the agent team watches the levels and the news for you.Create a free account

More TEM analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.